Appendiceal Neuroendocrine Tumors: Does Colon Resection Improve Outcomes?

Angelena Crown1,2, Vlad V Simianu1,2, Hagen Kennecke1

  • 1Digestive Disease Institute, Virginia Mason Medical Center, Seattle, WA, USA.

Abstract

Insights

Surgical strategy for appendiceal neuroendocrine tumors (A-NETs) does not impact recurrence-free survival or overall survival. Formal colon resection leads to more complications and longer hospital stays than appendectomy for A-NETs.

Area of Science:

  • Gastroenterology
  • Surgical Oncology
  • Pathology

Background:

  • Appendiceal neuroendocrine tumors (A-NETs) are rare gastrointestinal neoplasms.
  • Current management of A-NETs primarily relies on tumor size, with limited understanding of surgical strategy's impact on outcomes.

Purpose of the Study:

  • To evaluate the impact of surgical resection strategy on short- and long-term outcomes for appendiceal neuroendocrine tumors (A-NETs).

Main Methods:

  • Retrospective analysis of 61 patients with A-NET undergoing resection across 8 institutions (2000-2016).
  • Clinicopathologic features and outcomes were stratified based on surgical approach: appendectomy versus formal colonic resection.

Main Results:

  • Appendectomy was performed in 51% of patients, colonic resection in 49%.
  • The colonic resection group had a higher incidence of positive lymph nodes (27%) and advanced disease (M1, 3%).
  • Complications (30% vs 6%, p=0.02), length of stay, blood loss, and operative time were significantly higher in the colonic resection group, despite similar R0 resection rates (90% vs 97%) and outcomes (RFS, OS).

Conclusions:

  • Recurrence-free survival (RFS) and overall survival (OS) for A-NETs are comparable irrespective of surgical approach.
  • Formal colonic resection is associated with increased morbidity and resource utilization compared to appendectomy.
  • Further research is needed to identify specific patient subgroups who may benefit from more aggressive surgical interventions.